Le Lézard
Classified in: Health, Business
Subjects: PDT, JVN

Kent Imaging Announces Strategic Partnership to Advance Tissue Assessment


CALGARY, March 20, 2018 /PRNewswire/ - Kent Imaging Inc. announced today a strategic relationship with Allergan Canada to advance tissue assessment in Canada.

This opportunity adds the Kent device to Allegan Canada's Medical Aesthetics division with another solution for breast augmentation surgery along with AlloDerm®, Natrelle®, Revolve®, and the Keller Funnel®

The Kent device is intended for use by healthcare professionals as a non-invasive tissue oxygenation measurement system that reports oxygen saturation (StO2), relative oxyhemoglobin level (HbO2), and relative deoxyhemoglobin (Hb) level in superficial tissue. Kent's multispectral imaging technology displays two-dimensional colour-coded images providing critical information to help physicians determine at risk tissue and guide treatments to optimize patient outcomes in breast, reconstructive, and various other plastic surgery applications.

"With the Kent device, we can quantify oxygenation which is the best biomarker for tissue health and predictor of tissue viability in creating flaps with surgically reconstructed patients," said Carmen Enciu, Medical Director and Head of the Canadian Chief Medical Office. "This opportunity further reinforces Allergan Canada's commitment to patients in need of treatment by finding innovative technologies that improve outcomes." 

"We are very excited about this strategic partnership", said Pierre Lemire, CEO of Kent Imaging. "Working with Allergan Canada, we can help physicians determine the most effective treatment plans which provides them a means of reducing recovery times and patient discomfort, as well as optimizing patient outcomes."  

Features of Kent's Tissue Oxygenation Assessment device:

Kent is now available for sale in both the United States and Canada.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading developer of medical technology, who designs, manufactures and markets imaging technology for wound and surgical care. Kent holds multiple patents in medical technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about our company visit us at www.kentimaging.com.

About Allergan plc

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model ? Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.

Allergan's success is powered by our global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan's website at www.Allergan.com

SOURCE Kent Imaging


These press releases may also interest you

at 06:37
According to a Department of Justice press release, a South Carolina man was recently sentenced to serve time in federal prison after a criminal tax conviction. This story should serve as a reminder that the consequences of intentionally dodging tax...

at 06:17
NEI Global Relocation's latest whitepaper, "2024 Relocation Trends | Manufacturing," provides a compelling look into how innovative relocation strategies are crucial for the manufacturing sector's talent acquisition and retention efforts. This comes...

at 06:13
JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") , one of the largest and most innovative solar module manufacturers in the world, today announced that since March 20, 2024, the Company has repurchased 788,178 American depositary shares...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:00
G-P (Globalization Partners), the recognized leader in the global employment market, and standard bearer for industry compliance, today announced it was awarded 50 leader badges in G2's 2024 Spring Report, including Employer of Record Leader, Global...

at 05:45
The Gross Law Firm issues the following notice to shareholders of New York Community Bancorp, Inc. . Shareholders who purchased...



News published on and distributed by: